RESEARCH FIELD
Product Layout
Comprehensive Pipeline to Seize the Trend of Cancer Chronicization
Backbone oncology products
Core mono/combo backbone product structure
Envafolimab (first subcutaneous injection PD-L1 mAb worldwide): Pan-cancer, multiple indications
3D189 (WT1): Cancer Vaccine for multiple indications
3D229 (GAS6/AXL): NSCLC / OC / RCC / UC
Pain management solutions
Complemented by pain management solutions
3D1002 (EP-4): Cancer pain / osteoarthritis
3D1001 (COX-2): Post-surgical dental pain / cancer pain
Future leading products
Future leading products synergetic with other assets
3D197: IO therapy targeting at multiple indications
3D185 (FGFR1/2/3): Locally advanced or metastatic solid tumors
3D011 (TKI prodrug): Advanced malignant solid tumors
3D057: Multiple indications
